U.S. Hospitality Stock News

In recent months, Celanese Corporation has been working through weak demand and excess capacity following its 2022 purchase of DuPont’s Mobility & Materials business, while projections now point to stronger free cash flow from 2025 and meaningful debt reduction by 2027. This shift suggests that the balance sheet impact of the DuPont acquisition may ease as cash generation improves and sector conditions gradually recover. Next, we’ll examine how expectations for stronger free cash flow and...

If you are wondering whether Skyworks Solutions is attractively priced or just a value trap, you are in the right place for a clear look at what the current share price could mean for long term investors. The stock closed at US$56.48 recently, with returns of 1.0% over the last 30 days but declines of 12.3% year to date and 11.9% over the past year, which hints at shifting expectations around its prospects and risk profile. Recent coverage on Skyworks has focused on its position within the...

Why AT&T (T) is on investors’ radar right now AT&T (T) has attracted fresh attention after recent share price moves, with the stock showing a mix of short term fluctuations and longer term returns that stand out against its current valuation metrics. See our latest analysis for AT&T. AT&T’s recent 7 day share price return of 5.5%, 30 day return of 8% and 90 day return of 14.6% suggest momentum has been building. Its 1 year total shareholder return of 13.1% and 3 year total shareholder return...

Tenable Holdings (TENB) has drawn fresh attention after filing a US$135.1 million shelf registration for 7,699,248 shares tied to its employee stock ownership plan, coinciding with a recent reset in analyst sentiment. See our latest analysis for Tenable Holdings. That ESOP related shelf registration lands just as short term momentum has picked up, with a 9.29% 7 day share price return and 5.64% 30 day share price return. At the same time, the 1 year total shareholder return of 43.26% and 5...

Dividend decision follows earnings momentum Veralto (VLTO) has paired its fourth consecutive quarterly earnings beat and full-year adjusted earnings per share growth of about 10% with a newly affirmed quarterly cash dividend of US$0.13 per share. The dividend, payable on April 30, 2026 to shareholders of record as of March 31, 2026, gives investors a clearer view of how management is currently balancing cash returns with its outlook for low to mid single digit core sales growth and modest...

Why Exelon (EXC) is on investors’ radar today Exelon (EXC) has drawn fresh attention after recent share price moves, with the stock closing at $48.77 and showing positive total returns over the past year and past 3 months. See our latest analysis for Exelon. While the share price has eased slightly over the last day, the recent 30 day share price return of 10.82% and 1 year total shareholder return of 17.78% point to building momentum, supported by longer term gains over 3 and 5 years. If...

Eli Lilly (NYSE:LLY) has launched Employer Connect, a new platform aimed at expanding access to obesity care medicines in the U.S. The program allows employers to coordinate benefits with more than fifteen independent administrators to support access to treatments such as Zepbound. Employer Connect focuses on addressing coverage gaps, costs, and support services for employees seeking obesity care. Eli Lilly, known for its growing obesity care portfolio that includes Zepbound, is putting...

Jabil (NYSE:JBL) plans to wind down manufacturing operations at its Clinton, Massachusetts facility. Production from Clinton is set to be relocated to the company’s site in Devens, Massachusetts. Certain subsidiaries are expected to remain at the Clinton complex after the transition. The company is outlining severance and job placement assistance for affected employees. Jabil, a large manufacturing services provider, is reshaping its Massachusetts footprint by concentrating production in...

Illumina (NasdaqGS:ILMN) and Nashville Biosciences have expanded the Alliance for Genomic Discovery with the addition of Regeneron Genetics Center. The group is launching a large-scale multiomics program that pairs whole genome data with proteomic information. Pharmaceutical partners such as GSK are participating in the effort, which focuses on genomic diversity and clinically linked datasets. For you as an investor, this update sits at the core of what Illumina does, providing tools and...

Why Wolverine World Wide Stock Is Back on Watch Lists Wolverine World Wide (WWW) is drawing fresh attention after recent share price weakness, with the stock down over the past week, month and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for Wolverine World Wide. At a latest share price of $16.59, Wolverine World Wide has seen a 1 day share price decline of 6.48% and a 7 day share price decline of 16.97%. Its 1 year...

Hershey triggered: stock performance draws closer look Hershey (HSY) has caught investor attention after a recent stretch of mixed returns, including a 2.4% decline over the past day and a 2.1% decline over the past week, alongside stronger performance over the past month and past 3 months. See our latest analysis for Hershey. At a share price of US$226.58, Hershey’s recent pullback over the past week comes after a strong rebound, with a 1 month share price return of 12.46% and a 3 month...

MercadoLibre is ramping up spending on digital banking, AI-powered tools, and expanded credit across Latin America. The company is prioritizing Brazil, while rolling out digital banks in Mexico and Argentina and issuing millions of new credit cards. These moves reflect a choice to accept lower short term margins in order to build out its broader e-commerce and fintech ecosystem. MercadoLibre, traded as NasdaqGS:MELI, is leaning into its role as a combined e-commerce and fintech platform...

If you are looking at Choice Hotels International and wondering whether the recent price is giving you value or just noise, you are not alone. The stock closed at US$106.35, with a 1.5% decline over the last 7 days, a 4.8% gain across 30 days, a 10.7% gain year to date, but a 24.5% decline over 1 year and a 7.5% decline across 3 years, while the 5 year return sits at 3.5%. These mixed returns sit against a backdrop of ongoing interest in hotel operators, including discussions around travel...

Watts Water Technologies overview With no single headline event driving attention today, Watts Water Technologies (WTS) is on some investors radar because of its recent share performance and financial profile within the building solutions and fluid management space. See our latest analysis for Watts Water Technologies. Recent trading has cooled slightly, with a 2.0% one day share price decline and a 5.1% seven day share price return pullback. However, the 12.4% year to date share price return...

AES Corporation (NYSE:AES) agreed to a take-private acquisition valued at about $33 billion. The buyer group includes Global Infrastructure Partners, EQT, CalPERS, and Qatar Investment Authority. The deal has drawn scrutiny from officials and consumer advocates over potential rate impacts and transparency. AES is seeking consent amendments with creditors to address possible change-of-control triggers. AES is a global power company with a mix of fossil fuel and clean energy assets, which...

Weatherford International (WFRD) has drawn fresh attention after recent trading left the stock about 1.6% lower on the day and roughly 10% down over the past week, bringing its recent performance into sharper focus. See our latest analysis for Weatherford International. That short term pullback sits against a stronger backdrop, with a 23.34% 3 month share price return and a very large 5 year total shareholder return of about 7x. This suggests that recent momentum has cooled after a longer...

Calvin B. Taylor Bankshares (TYCB) closed out FY 2025 with fourth quarter revenue of US$10.1 million and Basic EPS of US$1.34, rounding out a year where trailing twelve month revenue was US$39.1 million and EPS reached US$5.66. Over recent periods the company has seen revenue move from US$32.8 million and EPS of US$4.77 on a trailing basis in Q4 2024 to US$39.1 million and EPS of US$5.66 by Q4 2025, while quarterly revenue ranged between US$9.1 million and US$10.1 million and EPS between...

Sunrun (RUN) is back in focus after reporting full year 2025 results that moved from a multibillion dollar loss to US$449.95 million in net income, along with continued progress in grid services and financing partnerships. See our latest analysis for Sunrun. Despite the return to profitability and progress in grid services partnerships, Sunrun’s recent share price has come under pressure. The 7 day share price return is 42.26% and the 30 day share price return is 36.17%, while the 1 year...

If you are wondering whether lululemon athletica's current share price lines up with its real worth, you are not alone. This article is built to help you frame that question clearly before you act. The stock last closed at US$173.18, after a 6.9% decline over the past 7 days and returns of 0.9% over 30 days, while the year to date return is a 17.9% decline and the 1 year return is a 50.2% decline, compared to a 42.6% decline over 3 years and a 44.2% decline over 5 years. These moves have...

In February 2026, iRhythm Holdings (NASDAQ: IRTC) reported its fourth-quarter and full-year 2025 results, achieving its first quarter of positive GAAP profitability, supported by novel care channels, international expansion, and steady demand in its core U.S. business. This shift into GAAP profitability suggests that iRhythm’s diversified growth engines are beginning to cover its cost base, potentially altering how investors assess its sustainability and risk profile. We’ll now examine how...

PROCEPT BioRobotics (PRCT) is back in the spotlight after reporting fourth quarter and full year 2025 results, followed quickly by new 2026 and 2027 guidance and fresh analyst commentary. See our latest analysis for PROCEPT BioRobotics. After a sharp selloff over the past year, including a 90 day share price return decline of 29.31% and a 1 year total shareholder return loss of 58.15%, PROCEPT BioRobotics is trying to rebuild confidence as recent earnings, new 2026 and 2027 guidance and fresh...

If you are trying to figure out whether CoreWeave's share price actually lines up with its underlying worth, you are in the right place. The stock last closed at US$74.82, after returns of 23.4% decline over the past 7 days, a 16.9% decline over 30 days and a 5.7% decline year to date, which may have changed how investors think about its risk and potential. Recent headlines have kept CoreWeave in focus for investors, including coverage of its position within the AI focused infrastructure and...

If you are wondering whether BILL Holdings at around US$45.13 is priced for a recovery or still facing skepticism, you are in the right place to unpack what that means for value. The stock has recorded a 3.6% gain over the last 7 days and a 21.8% return over the past month, even though the year to date return is a 10.7% decline and the 1 year return is a 5.3% decline, while the 3 year and 5 year returns stand at 43.8% and 70.9% declines respectively. Recent coverage has focused on BILL...

In February 2026, Enovix Corporation reported fourth-quarter 2025 sales of US$11.27 million and a net loss of US$34.99 million, alongside full-year 2025 sales of US$31.82 million and a net loss of US$156.74 million, all showing year-on-year improvement in both revenue and loss per share. Investors also received first-quarter 2026 revenue guidance of US$6.5 million to US$7.5 million, giving clearer visibility into near-term commercial traction as the company continues to scale its battery...